Insight Molecular Diagnostics Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Insight Molecular Diagnostics Inc. (IMDX) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $22.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2024-11-12
- 2024-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $22.00K.
- 2024-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $44.00K.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $66.00K.
- 2023-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $22.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2024-09-30 | $22.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $44.00K 10-Q · filed 2024-08-08 |
| 2023-12-31 | $66.00K 10-Q · filed 2024-05-15 |
| 2023-09-30 | $22.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $44.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $66.00K 10-Q · filed 2023-05-15 |
| 2022-09-30 | $976.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.95M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $2.93M 10-Q · filed 2022-05-12 |
| 2021-09-30 | $990.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |